AI channel feed

Q&A: Bris­tol My­ers’ tech chief on the promis­es and per­ils of AI bio

7 months ago
People
R&D

Ex­clu­sive: Flag­ship-backed Va­lo Health los­es in­ter­im CEO ahead of key Phase 2 read­out

7 months ago
People
Startups

With few ef­fi­ca­cy de­tails, In­sil­i­co claims a Phase 2a win in lat­est AI read­out

7 months ago
R&D

Gilead part­ners with AI start­up Gen­e­sis Ther­a­peu­tics to make small mol­e­cule drugs

8 months ago
Deals

Eli Lil­ly in­vests in Su­per­lu­mi­nal's $120M Se­ries A round as AI-fo­cused star­tups eye the clin­ic

8 months ago
Financing

Ex­clu­sive: Zip­Bio launch­es us­ing gen­er­a­tive AI to make com­pact pro­teins

8 months ago
Financing
Startups

With few specifics, Re­cur­sion un­der­whelms with first Phase 2 read­out, but ‘plans to ad­vance’ drug

8 months ago
R&D

Re­cur­sion nears ‘mo­ment of truth’ with first key da­ta, kick­ing off 18-month flur­ry of read­outs

8 months ago
R&D
In Focus

Ex­clu­sive: Noetik rais­es $40M Se­ries A to ad­vance AI am­bi­tions in can­cer — with an un­like­ly lead in­vestor

8 months ago
Financing
Startups

In a re­al­i­ty check for the field, AI un­der­whelms in Leash Bio's bind­ing con­test: 'No one did well'

8 months ago

Up­dat­ed: Re­cur­sion to ac­quire Ex­sci­en­tia to bol­ster pipeline in one of AI bio’s biggest M&A deals

9 months ago
Deals

FDA grap­ples with its role in AI, and how to guide in­dus­try's adop­tion

9 months ago
R&D
FDA+

Q&A: Genen­tech's new CEO on AI, IRA and ra­dio­phar­ma

9 months ago
People
R&D

Besse­mer VC Mor­gan Cheatham shares how AI health­care star­tups can win in a crowd­ed mar­ket

9 months ago
People
Health Tech

Health tech start­up Com­mure bets on AI for med­ical notes in $139M deal

9 months ago
Startups
Deals

Where Oak HC/FT in­vestor Nan­cy Brown is plac­ing her bets on AI in health tech

9 months ago
Startups
Health Tech

With a $372M megaround, For­ma­tion Bio looks to in-li­cense 10+ drugs

10 months ago
Financing

Lil­ly be­comes the lat­est phar­ma to tap Ope­nAI for help, this time for an­tibi­ot­ic work

10 months ago
R&D
Pharma

Ex-Meta sci­en­tists launch Evo­lu­tion­aryScale with $142M seed round, un­veil­ing next-gen AI mod­el for pro­tein de­sign

10 months ago
Financing
Startups

The End­points Slack in­ter­view: Saji Wick­ra­masekara on where AI miss­es the mark — and what's next for Bench­ling

10 months ago
In Focus
Health Tech

Obe­si­ty care start­up known­well buys an AI weight loss plat­form

10 months ago
Deals
Health Tech

How two aca­d­e­m­ic chemists turned San Diego start­up Iambic in­to an AI force

10 months ago
In Focus

AI drug dis­cov­ery start­up goes pub­lic in Hong Kong, nab­bing $115M to build on phar­ma part­ner­ships

11 months ago
Financing
China

AI is un­like­ly to take off among CD­MOs at the same scale as bio­phar­ma com­pa­nies, in­sid­ers say

11 months ago
Manufacturing
First page Previous page 1234567 Next page Last page
A service from the Financial Times